首页> 外国专利> Recombinase made to measure to recombine asymmetric target sites in a plurality of retrovirus strains

Recombinase made to measure to recombine asymmetric target sites in a plurality of retrovirus strains

机译:用于重组重组逆转录病毒株中不对称靶位点的重组酶

摘要

Method for preparing an expression vector encoding a custom-made recombinase, said custom-made recombinase being able to recombine asymmetric target sequences within the LTR of DNA from a plurality of retrovirus strains that are strains of HIV-1, comprising the following steps: (a) identify sequences with a homology of at least 30% with respect to the left hemisphere sequence and right hemisphere sequence of at least one recombinase target site known in the LTR sequence of the proviral DNA of a plurality of retrovirus strains, in which the homologous sequences are separated by a spacer of 5 to 12 nucleotides and in which the asymmetric target sequence is found in a plurality of retrovirus strains, in which the asymmetric target sequence presents the sequence set forth as SEQ ID No. 1, (b) identifying two sequences, in which the first sequence corresponds to the sequence of the asymmetric target sequence of step (a) homologous to the left hemisphere of said known target site and referred to as "hemisphere sequence 1" and in which the second sequence corresponds to the sequence of the asymmetric target sequence from step (a) homologous to the right hemisphere and referred to as "hemisphere sequence 2"; (c) determining the nucleotides within the sequences of stage (b) that differ from the corresponding homologous left hemisphere and right hemisphere sequences of said at least one known homologous target site of stage (a); (d) generating a first subset of two target nucleic acids comprising target sequences, in which the first target sequence is called subsite 1 and comprises, adjacent to each other and in order 5 'to 3', the hemisphere sequence 1 of step (b), the spacer sequence of the asymmetric target sequence and an inverted repeat of hemisphere sequence 1, and in which the second target sequence is called subsite 2 and comprises, adjacent to each other and in order 5 'to 3 ', an inverted repeat of the hemisphere sequence 2, the spacer sequence of the asymmetric target sequence and the hemisphere sequence 2 of step 30 (b), (e) generate a second subset of target nucleic acids comprising target sequences modified on the basis of the target sequences of the first subset of step (d), in which, in the sequences based on subsite 1, in the left hemisphere sequence, a part of the nucleotides that differ from the corresponding homologous hemisphere sequence of at least one known target site of step (a) is replaced by the natural nucleotides found in said known target site, until said hemisphere sequence contains one, two or three nucleotides that differ from said known target site, in which the right hemisphere of said modified target sequence is formed by an inverted repetition of said modified left hemisphere sequence, which is separated from said modified left hemisphere sequence by the spacer sequence of the asymmetric target sequence, and wherein, in the sequences based on subsite 2, in the right hemisphere sequence, a part of the nucleotides that differ from the corresponding homologous hemisphere sequence of said at least one known target site of step (a ) is replaced by the natural nucleotides found in said known target site, until said sequence of h emisitio contains one, two or three nucleotides that differ from said known target site, in which the left hemisphere of said modified target sequence is formed by an inverted repetition of said modified right hemisphere sequence, which is separated from said modified sequence of right hemisphere by the spacer sequence of the asymmetric target sequence, so that in all the modified hemisphere sequences originated from a target sequence of the first subset of step (d) taken together, all the differentiated nucleotides can be found , while none of said modified hemisphere sequences alone comprises all the differentiated nucleotides, (f) separately applying the molecular evolution directed to at least one recombinase that recognizes a known homologous target site according to step (a) using each nucleic acid of the second subset obtained in step (e) as substrate, (g) mixing the collections of recombinases evolved in step (f), in which all collections of recombinases evolved on sequences based on subsite 1 are combined and mixed, and in which all collections of recombinases evolved on sequences based on subsite 2, they are combined and mixed; (h) apply the molecular evolution directed to the mixed collections obtained in step (g) using each nucleic acid of the subset according to step (d) as a substrate; (i) mix the collections of recombinases evolved in step (h); (j) applying the substrate bound protein evolution of the mixed collection obtained in step (g) using a nucleic acid comprising the asymmetric target sequence of step (a) as a substrate, until at least one recombinase that is active on the asymmetric target sequence within the retroviral DNA LTR of step (a); (k) isolating the nucleic acid encoding said at least one recombinase obtained in step (j) from the collection; and (l) cloning the nucleic acid obtained in step (k) into a suitable expression vector.
机译:制备编码定制重组酶的表达载体的方法,所述定制重组酶能够重组来自HIV-1毒株的多个逆转录病毒株的DNA LTR内的不对称靶序列,包括以下步骤:( a)鉴定与在多个逆转录病毒株的原病毒DNA的LTR序列中已知的至少一个重组酶靶位点的左半球序列和右半球序列具有至少30%的同源性的序列,其中同源序列被5至12个核苷酸的间隔区隔开,并且其中在多个逆转录病毒株中发现了不对称靶序列,其中不对称靶序列呈现出SEQ ID No.1所示的序列,(b)鉴定了两个序列,其中第一序列对应于步骤(a)的不对称靶序列的序列,该步骤与所述已知靶位点和参照物的左半球同源d表示为“半球序列1”,其中第二序列对应于来自步骤(a)的与右半球同源的不对称靶序列的序列,并称为“半球序列2”; (c)确定阶段(b)的序列中与所述阶段(a)的所述至少一个已知同源靶位点的相应同源左半球和右半球序列不同的核苷酸; (d)产生包含靶序列的两个靶核酸的第一子集,其中所述第一靶序列被称为亚位点1,并且包含彼此相邻且以5'至3'的顺序的步骤(b)的半球序列1 ),不对称靶序列的间隔子序列和半球序列1的反向重复序列,其中第二个靶序列被称为亚位点2,并且以5'至3'的顺序彼此相邻地包含一个步骤30(b),(e)的半球序列2,不对称靶序列的间隔子序列和半球序列2产生靶核酸的第二子集,其包含基于第一靶序列的靶序列修饰的靶序列。步骤(d)的子集,其中在基于亚位点1的序列中,在左半球序列中,与步骤(a)的至少一个已知靶位点的相应同源半球序列不同的一部分核苷酸是代表被在所述已知靶位点中发现的天然核苷酸包围,直到所述半球序列包含与所述已知靶位点不同的一个,两个或三个核苷酸,其中所述修饰靶序列的右半球通过所述修饰序列的反向重复形成左半球序列,其通过不对称靶序列的间隔子序列与所述修饰的左半球序列分开,并且其中,在基于亚位点2的序列中,在右半球序列中,一部分核苷酸与相应的步骤(a)的所述至少一个已知靶位点的同源半球序列被在所述已知靶位点中发现的天然核苷酸替换,直到所述半胱氨酸序列包含与所述已知靶位点不同的一个,两个或三个核苷酸,其中所述修饰的靶序列的左半球是由所述修饰的右半球序列的反向重复形成的, h通过不对称靶序列的间隔区序列与所述右半球的修饰序列分开,使得在源自步骤(d)的第一子集的靶序列的所有修饰的半球序列中,所有分化的核苷酸可以可以发现,虽然所述修饰的半球序列没有一个单独包含所有已分化的核苷酸,(f)使用步骤(a)中的每个核酸分别应用针对至少一种识别已知同源靶位点的重组酶的分子进化。在步骤(e)中获得的第二个子集作为底物,(g)混合在步骤(f)中进化的重组酶集合,其中将基于亚位点1的序列进化的所有重组酶集合并混合,并且其中重组酶是根据基于亚位点2的序列进化而来的,将它们合并和混合; (h)以根据步骤(d)的子集的每个核酸为底物,对步骤(g)中获得的混合收集物进行分子进化; (i)混合在步骤(h)中产生的重组酶的集合; (j)使用包含步骤(a)的不对称靶序列的核酸作为底物,应用步骤(g)中获得的混合收集物的底物结合蛋白进化直至在步骤(a)的逆转录病毒DNA LTR内对不对称靶序列具有活性的至少一种重组酶; (k)从收集物中分离编码步骤(j)中获得的编码所述至少一种重组酶的核酸; (l)将步骤(k)中获得的核酸克隆到合适的表达载体中。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号